Related Experiment Video
Updated: Jun 17, 2026
Nanoparticle Delivery of an Oligonucleotide Payload in a Glioblastoma Multiforme Animal Model
Published on: September 27, 2024
Liposomal nanocarriers for tumor imaging
1Faculty of Pharmacy, Department of Radiopharmacy, Hacettepe University, 06100 Ankara, Turkey.
Abstract:
Currently used imaging modalities such as scintigraphy, computed tomography, magnetic resonance imaging and ultrasonography require the sufficient intensity of a corresponding signal from an area of interest to differentiate this area from the surrounding tissues. Targeting of various reporter moieties directly to the specific organs, tissues or tumors provide the highest dose of drug directly where it is needed. Many different types of nanoparticles are currently being studied for applications in nanomedicine. Among particulate drug carriers, liposomes are one of the most extensively studied and possess the most suitable characteristics for encapsulation of many drugs, genes, and diagnostic (imaging) agents. Among the many potential targets for such nanocarriers, tumors have been most often investigated. This review attempts to summarize the currently available information regarding liposomal nanocarriers for cancer imaging.
Insights
Liposomal nanocarriers offer enhanced cancer imaging by delivering diagnostic agents directly to tumors. This review explores their potential to improve upon current imaging techniques for more targeted cancer detection.
Area of Science:
- Nanomedicine
- Biomedical Imaging
- Drug Delivery Systems
Background:
- Current imaging techniques (scintigraphy, CT, MRI, ultrasound) require strong signals for tissue differentiation.
- Targeting reporter molecules to specific sites maximizes therapeutic or diagnostic agent concentration.
- Tumors are a primary focus for nanocarrier applications in medicine.
Purpose of the Study:
- To review the current literature on liposomal nanocarriers for cancer imaging.
- To highlight the advantages of liposomes as drug delivery vehicles for diagnostic purposes.
- To summarize the potential of liposomes in improving tumor visualization.
Main Methods:
- Literature review of studies on liposomal nanocarriers in cancer imaging.
- Analysis of nanoparticle characteristics relevant to drug encapsulation and targeting.
- Evaluation of tumor-specific delivery strategies using liposomes.
Main Results:
- Liposomes are well-suited for encapsulating imaging agents.
- Targeted liposomes can concentrate diagnostic signals within tumors.
- Liposomal nanocarriers show promise for enhancing cancer detection sensitivity.
Conclusions:
- Liposomal nanocarriers represent a promising platform for advanced cancer imaging.
- Further research into targeted liposomal systems can improve diagnostic accuracy.
- Liposomes offer a versatile approach for integrating therapy and diagnostics in oncology.
